The first FDA-approved, cannabinoid-based pharmaceutical drug is now for sale in the U.S. After clearing all regulatory requirements, GW Pharmaceuticals’ CBD-based drug Epidiolex is now available in all 50 states. Although the U.S. government is now allowing this drug to be sold, the federal government still classifies actual cannabis as a Schedule I illegal substance.
